All articles by GlobalData 

  1. IDWeek 2019: Climate change poses risks for the spread of infectious diseases

    On 4 October, healthcare practitioners and stakeholders gathered at IDWeek 2019 in Washington DC to discuss issues related to the…
    Read More…

    8 Oct
  2. Novartis’ Zolgensma has Phase I trial planned for 2020 to evaluate SMA infants who present neutralising antibodies, source says

    Novartis (SIX:NOVN) has a Phase I Zolgensma (onasemnogene abeparvovec-xioi) study planned to initiate in 2020 for infants with spinal muscular…
    Read More…

    31 Jul
  3. Stealth’s Phase III elamipretide in mitochondrial myopathy has experts wary while FDA approval debated

    Stealth BioTherapeutics’ elamipretide in primary mitochondrial myopathy (PMM) has experts reserved on Phase III achieving statistical success in its walk…
    Read More…

    17 Jun
  4. Amarin’s Vascepa, AstraZeneca’s Epanova theoretical cardiovascular risk reduction class effect possibly stifled

    Although Amarin’s Vascepa (icosapent ethyl) is likely to lock in US Food and Drug Administration approval and swift uptake in…
    Read More…

    17 Jun
  5. Positive results reported for Eli Lilly’s ultra-rapid insulin

    During the American Diabetes Association’s (ADA’s) 79th Scientific Sessions held in San Francisco, California, US, delegates were able to hear…
    Read More…

    17 Jun
  6. Signs of advancement in metastatic hormone-naive prostate cancer treatment

    Among this year’s biggest developments in prostate cancer was the release of data in patients with metastatic hormone-naive prostate cancer…
    Read More…

    17 Jun
  7. Erleada looks to advance treatment of metastatic hormone-sensitive prostate cancer paradigm

    During this year’s American Society of Clinical Oncology (ASCO 2019) meeting in Chicago, several prostate cancer trials of second-generation hormonal…
    Read More…

    13 Jun
  8. Eli Lilly is likely to establish Emgality in the preventative migraine market

    The migraine market has many unmet needs. In the preventative treatment of migraines, the market is dominated by non-specific drugs…
    Read More…

    13 Jun
  9. Characterising Eastern China’s pharmaceutical manufacturing market: Shandong and Jiangsu

    The following article is the second of two articles covering Eastern China, specifically Shandong and Jiangsu (eastern provinces north of the…
    Read More…

    13 Jun
  10. Stroke: a growing burden across eight major markets to 2027

    A stroke occurs when blood supply to the brain is interrupted by a clot or when a blood vessel bursts….
    Read More…

    12 Jun
Close
Close
Close

Go Top